Janux Therapeutics Inc (JANX)
27.00 x 1 30.26 x 3
Post-market by (Cboe BZX)
29.10 -0.68 (-2.28%) 03/28/25 [NASDAQ]
27.00 x 1 30.26 x 3
Post-market 29.10 unch (unch) 16:02 ET
for Fri, Mar 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
| 12-2019 | 12-2017 | 12-2006 | 12-2005 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,004 | N/A | N/A | N/A | -9,050 |
| Depreciation Amortization | 6 | N/A | N/A | N/A | 3 |
| Accounts payable and accrued liabilities | 4 | N/A | N/A | N/A | N/A |
| Other Working Capital | -69 | N/A | N/A | N/A | 1,130 |
| Other Operating Activity | 235 | 0 | 0 | 0 | 7,637 |
| Operating Cash Flow | $-3,828 | $N/A | $N/A | $N/A | $-280 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $0 | $N/A | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 4,000 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | 280 |
| Financing Cash Flow | $4,000 | $N/A | $N/A | $N/A | $280 |
| Beginning Cash Position | 486 | N/A | N/A | N/A | 4 |
| End Cash Position | 658 | N/A | N/A | N/A | 5 |
| Net Cash Flow | $172 | $N/A | $N/A | $N/A | $1 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,828 | N/A | N/A | N/A | -280 |
| Free Cash Flow | -3,828 | 0 | 0 | 0 | -280 |